Inhibrx, Inc.
NASDAQ:INBX
14.6 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.1 | 0 | 1.634 | 0.119 | 0.03 | 0.017 | 0.274 | 0.278 | 0.711 | 0.915 | 2.836 | 2.508 | 0.918 | 0.863 | 2.776 | 5.826 | 3.334 | 0.872 | 0.267 | 0.794 | 1 | 7.032 | 2.269 | 2.5 | 2.5 | 0.281 |
| Cost of Revenue
| 0 | 0.475 | 0.36 | 0.298 | 0.304 | 0.731 | 0.722 | 0.72 | 0.719 | 29.906 | 0 | 0 | 0 | 0 | 16.438 | 0 | 19.837 | 18.974 | 0 | 0.004 | 12.785 | 12.174 | 10.665 | 4.68 | 8.495 | 10.779 | 7.289 |
| Gross Profit
| 0 | -0.375 | -0.36 | 1.336 | -0.185 | -0.701 | -0.705 | -0.446 | -0.441 | -29.195 | 0.915 | 2.836 | 2.508 | 0.918 | -15.575 | 2.776 | -14.011 | -15.64 | 0.872 | 0.263 | -11.991 | -11.174 | -3.633 | -2.411 | -5.995 | -8.279 | -7.008 |
| Gross Profit Ratio
| 0 | -3.75 | 0 | 0.818 | -1.555 | -23.367 | -41.471 | -1.628 | -1.586 | -41.062 | 1 | 1 | 1 | 1 | 1.03 | 1 | 1.013 | 1.001 | 1 | 0.985 | 1.535 | 3.209 | 1.212 | -1.063 | 1.124 | 1.117 | -24.94 |
| Reseach & Development Expenses
| 38.893 | 67.632 | 63.595 | 81.839 | 38.057 | 34.106 | 37.386 | 30.451 | 24.934 | 29.906 | 24.895 | 18.615 | 18.485 | 17.902 | 16.438 | 17.668 | 19.837 | 18.974 | 17.016 | 12.283 | 12.785 | 12.174 | 10.665 | 4.68 | 8.495 | 10.779 | 7.289 |
| General & Administrative Expenses
| 7.904 | 93.366 | 9.974 | 7.832 | 7.889 | 7.263 | 6.397 | 5.323 | 5.347 | 5.402 | 5.051 | 3.645 | 2.848 | 2.853 | 3.009 | 2.215 | 1.622 | 1.532 | 1.467 | 4.434 | 1.481 | 1.636 | 1.467 | 1.671 | 0.989 | 0.911 | 0.88 |
| Selling & Marketing Expenses
| 0 | 0 | -0.104 | -0.046 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.904 | 93.366 | 9.87 | 7.786 | 7.889 | 7.263 | 6.397 | 5.323 | 5.347 | 5.402 | 5.051 | 3.645 | 2.848 | 2.853 | 3.009 | 2.215 | 1.622 | 1.532 | 1.467 | 4.434 | 1.481 | 1.636 | 1.467 | 1.671 | 0.989 | 0.911 | 0.88 |
| Other Expenses
| 0 | 0 | -0.059 | -0.158 | -5.96 | -0.217 | -5.15 | -5.416 | -5.322 | 0.017 | -0.014 | -1.785 | -0.001 | 0.005 | 0.016 | -0.539 | -4.452 | -0.005 | 0.01 | 0.001 | -0.07 | 0.004 | 0.012 | 0 | 0.012 | 0.028 | 0 |
| Operating Expenses
| 46.797 | 160.998 | 73.465 | 89.625 | 45.946 | 41.369 | 43.783 | 35.774 | 30.281 | 35.308 | 29.932 | 22.24 | 21.309 | 20.719 | 19.421 | 19.883 | 21.384 | 20.501 | 18.483 | 16.721 | 13.841 | 11.601 | 10.644 | 1.657 | 9.173 | 11.397 | 0.88 |
| Operating Income
| -46.797 | -160.898 | -73.825 | -88.289 | -45.827 | -41.339 | -43.766 | -35.5 | -30.003 | -34.597 | -29.017 | -19.404 | -18.801 | -19.801 | -18.558 | -17.107 | -15.558 | -17.167 | -17.611 | -16.454 | -13.047 | -10.601 | -3.612 | -4.082 | -6.673 | -8.897 | -7.888 |
| Operating Income Ratio
| 0 | -1,608.98 | 0 | -54.032 | -385.101 | -1,377.967 | -2,574.471 | -129.562 | -107.924 | -48.66 | -31.713 | -6.842 | -7.496 | -21.57 | -21.504 | -6.162 | -2.67 | -5.149 | -20.196 | -61.625 | -16.432 | -10.601 | -0.514 | -1.799 | -2.669 | -3.559 | -28.071 |
| Total Other Income Expenses Net
| 2.933 | 2,018.911 | -4.885 | -3.685 | -5.96 | -5.708 | -5.15 | -5.416 | -5.322 | -3.131 | -2.237 | -1.785 | -1.779 | -0.909 | -0.729 | -0.539 | -4.452 | -0.718 | -2.482 | 0.149 | -6.216 | -0.486 | -0.235 | -0.283 | -0.376 | -0.423 | -0.476 |
| Income Before Tax
| -43.864 | 1,858.013 | -78.71 | -91.974 | -51.787 | -47.047 | -48.916 | -40.916 | -35.325 | -37.728 | -31.254 | -21.189 | -20.58 | -20.71 | -19.287 | -17.646 | -20.01 | -17.885 | -20.093 | -16.305 | -19.263 | -11.087 | -3.847 | -4.365 | -7.049 | -9.32 | -8.364 |
| Income Before Tax Ratio
| 0 | 18,580 | 0 | -56.288 | -435.185 | -1,568.233 | -2,877.412 | -149.328 | -127.068 | -53.063 | -34.157 | -7.471 | -8.206 | -22.56 | -22.349 | -6.357 | -3.435 | -5.364 | -23.042 | -61.067 | -24.261 | -11.087 | -0.547 | -1.924 | -2.82 | -3.728 | -29.765 |
| Income Tax Expense
| 0 | 0.002 | 0.317 | -0.004 | 0.002 | 0.005 | -0.225 | -0.001 | 5.322 | 0.004 | 2.237 | -0.307 | 1.777 | 0.919 | 0.002 | 0.003 | 0.487 | 3.4 | 2.461 | 2.313 | 0.9 | -0.002 | 0.259 | 0.046 | 0.507 | 0.514 | -8.364 |
| Net Income
| -43.864 | 1,858.011 | -78.71 | -93.604 | -51.789 | -47.052 | -48.691 | -40.915 | -40.647 | -37.732 | -33.491 | -21.189 | -20.58 | -20.71 | -19.289 | -17.649 | -20.497 | -17.885 | -20.093 | -16.305 | -20.163 | -11.085 | -3.847 | -4.411 | -7.156 | -9.355 | -7.899 |
| Net Income Ratio
| 0 | 18,580 | 0 | -57.285 | -435.202 | -1,568.4 | -2,864.176 | -149.325 | -146.212 | -53.069 | -36.602 | -7.471 | -8.206 | -22.56 | -22.351 | -6.358 | -3.518 | -5.364 | -23.042 | -61.067 | -25.394 | -11.085 | -0.547 | -1.944 | -2.862 | -3.742 | -28.11 |
| EPS
| -2.84 | 128.35 | -1.44 | -1.73 | -1.1 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 | -0.47 | -0.77 | -0.5 | -0.7 | -0.57 | -0.7 | -0.39 | -0.13 | -0.24 | -0.25 | -0.32 | -0.44 |
| EPS Diluted
| -2.84 | 125.48 | -1.44 | -1.73 | -1.1 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 | -0.47 | -0.77 | -0.5 | -0.7 | -0.57 | -0.7 | -0.39 | -0.13 | -0.24 | -0.25 | -0.32 | -0.44 |
| EBITDA
| -46.797 | 1,863.849 | -73.465 | -87.991 | -43.334 | -38.847 | -41.058 | -35.5 | -30.003 | -34.273 | -28.673 | -19.404 | -18.503 | -19.498 | -18.251 | -17.107 | -15.558 | -16.923 | -17.345 | -16.216 | -12.595 | -10.597 | -2.836 | -3.883 | -6.496 | -8.718 | -7.761 |
| EBITDA Ratio
| 0 | 18,638 | 0 | -53.85 | -385.101 | -1,294.933 | -2,574.471 | -129.562 | -107.924 | -48.204 | -31.337 | -6.842 | -7.378 | -21.24 | -21.148 | -6.162 | -2.67 | -5.076 | -19.891 | -60.734 | -15.863 | -10.597 | -0.403 | -1.711 | -2.598 | -3.487 | -27.619 |